fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • Read the study description and study information document.
  • Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Description

New Zealand Clinical Research is trialling an investigational medicine that could help people with autoimmune disorders or blood cancers, (e.g. alopecia, vitiligo, large granular lymphocytic leukemia (LGLL)) that are associated with CD94. CD94 is a protein (receptor) found in the surface of immune cells.

The investigational medicine, DR-01 may help people with these autoimmune disorders or blood cancers by binding to the CD94 protein and reducing overaction [excessive action] of these cells.

This is an investigational medicine because it has not been approved by Medsafe or other drug regulatory authorities.

This study (2024 FULL 21752) is being funded by Dren Bio, Inc. and has been approved by the Health and Disability Ethics Committee.

Requirements

Healthy Males and Females

  • Aged between 18 – 65 years
  • Weigh between 40 – 120 kgs
  • BMI (Body Mass Index) between 18 – 35 kg/m2
  • Not currently taking any regular prescription medications
  • Smokers/Vapers allowed

What is Involved?

Study Visits: 1-night stay + 11 follow up visits

Reimbursement: Up to $3,100 before tax

Important Documents

Important documents to download and read

Pre-screening Form

Serenity

Pre screening for Serenity

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last two weeks or been in isolation?
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using a form of contraception?
Have you previously participated in a study with NZCR or any other organisation? Give details or leave blank if no
Any history of Tuberculosis?
Do you have any history of medical conditions relating to:
Do you have any history of cancer?
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
Have you donated blood or plasma in the last few months?
Do you have any allergies to foods, medications or anything else we should be aware of? Have you experienced anaphylaxis before?
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.